# Interest of Drug Reconciliation to Ensure the Continuity of the Treatment at Discharge

> **NCT05062655** · NA · UNKNOWN · sponsor: **Centre Hospitalier le Mans** · enrollment: 130 (estimated)

## Conditions studied

- Hospitalized Patient

## Interventions

- **OTHER:** Drug reconciliation

## Key facts

- **NCT ID:** NCT05062655
- **Lead sponsor:** Centre Hospitalier le Mans
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-03
- **Primary completion:** 2022-12-08
- **Final completion:** 2022-12-08
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2022-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05062655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05062655, "Interest of Drug Reconciliation to Ensure the Continuity of the Treatment at Discharge". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05062655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*